Drug Development

Articles

Xcelodose provides automated processing of API directly into capsules at low doses. The expansion of Xcelodose reinforces Juniper’s early stage capsule filling capability.CDMO Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, announced that it has expanded its Xcelodose powder micro-dosing system. This move reinforces the company’s early stage capsule filling capability.

Juniper Pharma Services Strengthens Capsule Capability with Xcelodose

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

While some industry trade groups are gunning for distinct, nonproprietary names for biosimilars (mostly providers, brand manufacturers, and patient advocacy groups), and others for common names (mostly biosimilar manufacturers, insurers, pharmacies, and the Federal Trade Commission [FTC]), some are requesting that no decisions be made at all at this stage in the game. Express Scripts, a large pharmacy benefit manager (PBM), submitted a comment to FDA asking that the regulatory agency hold off on naming decisions until it releases formal guidance on interchangeability first.

Express Scripts to FDA: Hold Off on Biosimilar Naming Decisions for Now

A study backed by the Centre of Regenerative Medicine found that laminins are crucial cell components that could help aid the commercial production of stem cell therapies.

Laminins Key to Production-Scale Stem Cell Development

Text from a merger prospectus reveals the termination fee for the proposed Pfizer-Allergan deal would change if any new tax regulations were passed prior to the closing of the transaction.

The $3.5-Billion Pharmaceutical Prenup

The University of Sheffield has appointed Cobra Biologics to advance novel fusion protein technology into Phase 1 clinical trials.

Cobra Biologics to Scale Production of Growth Hormone

BioOutsource releases informational video detailing issues associated with ADCC assays and how to effectively analyze them.

BioOutsource Releases Video Addressing Issues with using ADCC Assays

The UK’s National Biologics Manufacturing Centre will use Novasep’s BioSC Lab for protein purification.

UK Center Installs Protein Purification Technology

Almac is investing GBP16 million to expand its formulation and analytical development services and has successfully negotiated to operate in the Charnwood Campus in Loughborough, England.

Almac Expands Pharmaceutical Development Capacity

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Even though rising production and use of generic pharmaceuticals is saving billions for the nation’s healthcare system, policy makers continue to slap the industry with policies it claims will limit product development and sales.

Hard Times in Washington for Generic Drugs

GE Healthcare's KUBio prebuilt modules were shipped from Germany to JHL Biotech in Wuhan, China.

Formulation and Drug Delivery